TiumBio Co., Ltd. (KOSDAQ:321550)
10,560
+1,330 (14.41%)
At close: Apr 23, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 308.23 billion as of April 24, 2026. Its market cap has increased by 267.48% in one year.
Market Cap
308.23B
Enterprise Value
309.19B
Revenue
12.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,560.00
Market Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 308.23B, a decrease of -1.18%. That is a compound annual growth rate of -0.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 308.23B | 80.69% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 454.94B |
| S.Biomedics | 401.28B |
| Kangstem Biotech | 389.38B |
| Y-Biologics | 375.66B |
| curacle co.,ltd. | 340.86B |
| NIBEC | 305.79B |
| Bio Solution | 281.01B |
| ABION | 229.76B |